O
OssDsign
Develops implants for bone replacement
About OssDsign
OssDsign AB is a pioneering company specializing in the design and manufacture of implants and material technology for bone regeneration, particularly in cranioplasty and facial reconstructive surgery. The company operates in the medical device market, serving neurosurgeons, craniofacial surgeons, and patients requiring cranial and facial bone repair. OssDsign's business model revolves around leveraging clinical insights and proprietary material technology to create patient-specific, tailored solutions that enhance healing and regeneration. The company generates revenue through the sale of its innovative implants and related technologies, which are developed in collaboration with clinical researchers at Karolinska University Hospital and material science experts at Uppsala University. OssDsign's products are designed to improve surgical outcomes and patient recovery times, making them a valuable asset in the medical field.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2011
- Headquarters
- Uppsala kommun, Sweden
- Listing
- IPO 2019
- Employees
- 44
- Open positions
- None listed
- Dealroom signal
- 79.4/100
- Industry
- Health
- Sub-industry
- Medical Devices, BioTechnology
- Sector
- Biotech & Life Sciences, Spinout, science-based, Surgery, medical implants, Horizon Europe, Nordic Rising Star 2022, DT and LS, Biotechnology
- Technology
- Nanotech
- Business model
- Manufacturing
- Client focus
- b2c
- Investment activity
- 1 company, latest Nov 2020
- Capital deployed
- —
- Preferred round
- ACQUISITION
Latest news
Press, funding announcements and product moves mentioning OssDsign.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SECONDARY✓Other financing | Jun 2025 | $0 | — | Undisclosed | ↗ |
| POST IPO EQUITY✓Other financing | Jun 2025 | $4.2M | — | Undisclosed | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for OssDsign is 710 monthly website visits, down 90% over the last three months. OssDsign's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
 Lattice MedicalLattice Medical develops MATTISSE, a fully degradable 3D printed breast implant for natural, uncomplicated breast restoration |
Loos, France | Operational | 40 | $61M | $189M |
 XeltisRestorative cardiovascular devices enabling natural tissue regeneration. |
Eindhoven, Netherlands | Operational | |||
 TensiveDevelops innovative prostheses aiming to substitute silicone implants |
Milan, Italy | Operational | |||
 CroivalveTreating Heart Valve Disease |
Dublin, Ireland | Operational | |||
 HylomorphHylomorph is an innovative Medtech company engineering biomaterials to optimize the interface between implantable medical devices and tissues |
Zurich, Switzerland | Operational | |||
 Regentis BiomaterialsDeveloping groundbreaking tissue repair solutions |
Or Akiva, Israel | Operational | |||
 HealshapePersonalized, resorbable bioprosthesis for natural breast reconstruction |
Nantes, France | Operational | |||
 ProVerumRedefining Minimally Invasive Treatment for BPH |
Dublin, Ireland | Operational |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later8 investors entered at this stage
Karolinska Development
SEB Venture Capital
Linc- AMAdrigo Asset Management
Lancelot Asset Management- FIFSG Fund II
- TATAMT AB
The Financial of the Exchequer (LFDE)
Other known investors5 additional known investors
Uppsala University
Almi Invest
Fåhraeus Startup and Growth
Fouriertransform
Uppsala University Invest
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about OssDsign on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See OssDsign’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.